(ROL) Rollins - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US7757111049
Stock: Pest Control, Wildlife Control, Termite Protection, Workplace
Total Rating 53
Risk 91
Buy Signal -0.68
| Risk 5d forecast | |
|---|---|
| Volatility | 25.3% |
| Relative Tail Risk | -4.95% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.50 |
| Alpha | 5.70 |
| Character TTM | |
|---|---|
| Beta | 0.183 |
| Beta Downside | 0.135 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.33% |
| CAGR/Max DD | 0.78 |
EPS (Earnings per Share)
Revenue
Description: ROL Rollins March 01, 2026
Rollins, Inc. (NYSE: ROL) delivers pest- and wildlife-control services to residential and commercial clients across the United States and select international markets, operating both company-owned locations and a growing franchise network.
In its most recent fiscal year, Rollins generated approximately $2.5 billion in revenue, with an adjusted earnings per share of $3.31 and franchisee-related sales accounting for roughly 30 % of total revenue-a metric that has risen 4 % year-over-year.
The pest-control sector is being buoyed by climate-driven pest population spikes, a 4 % CAGR in demand for integrated pest-management services, and sustained growth in construction and food-service industries, all of which underpin Rollins’ near-term revenue outlook.
For a deeper dive into how these trends translate into valuation insights, consider exploring ValueRay’s analysis of ROL.
Headlines to watch out for
Residential pest control demand drives revenue growth | Commercial pest control contracts secure recurring income | Franchisee expansion boosts market penetration | Regulatory changes impact pesticide usage costs | Economic downturns reduce discretionary pest control spending
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 526.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.21 > 0.02 and ΔFCF/TA 0.13 > 1.0 |
| NWC/Revenue: -8.32% < 20% (prev -5.98%; Δ -2.34% < -1%) |
| CFO/TA 0.22 > 3% & CFO 678.1m > Net Income 526.7m |
| Net Debt (1.23b) to EBITDA (853.3m): 1.44 < 3 |
| Current Ratio: 0.60 > 1.5 & < 3 |
| Outstanding Shares: last quarter (482.8m) vs 12m ago -0.32% < -2% |
| Gross Margin: 51.91% > 18% (prev 0.53%; Δ 5139 % > 0.5%) |
| Asset Turnover: 126.2% > 50% (prev 120.2%; Δ 6.03% > 0%) |
| Interest Coverage Ratio: 25.51 > 6 (EBITDA TTM 853.3m / Interest Expense TTM 28.6m) |
Altman Z'' 2.73
| A: -0.10 (Total Current Assets 472.7m - Total Current Liabilities 785.5m) / Total Assets 3.14b |
| B: 0.28 (Retained Earnings 893.1m / Total Assets 3.14b) |
| C: 0.24 (EBIT TTM 728.6m / Avg Total Assets 2.98b) |
| D: 0.78 (Book Value of Equity 1.37b / Total Liabilities 1.77b) |
| Altman-Z'' Score: 2.73 = A |
Beneish M -3.01
| DSRI: 0.94 (Receivables 247.2m/236.4m, Revenue 3.76b/3.39b) |
| GMI: 1.01 (GM 51.91% / 52.69%) |
| AQI: 1.03 (AQ_t 0.67 / AQ_t-1 0.65) |
| SGI: 1.11 (Revenue 3.76b / 3.39b) |
| TATA: -0.05 (NI 526.7m - CFO 678.1m) / TA 3.14b) |
| Beneish M-Score: -3.01 (Cap -4..+1) = AA |
What is the price of ROL shares?
As of March 08, 2026, the stock is trading at USD 58.28 with a total of 1,579,425 shares traded.
Over the past week, the price has changed by -4.29%, over one month by -9.85%, over three months by -3.44% and over the past year by +14.07%.
Over the past week, the price has changed by -4.29%, over one month by -9.85%, over three months by -3.44% and over the past year by +14.07%.
Is ROL a buy, sell or hold?
Rollins has received a consensus analysts rating of 3.42.
Therefor, it is recommend to hold ROL.
- StrongBuy: 2
- Buy: 2
- Hold: 7
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the ROL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 63.7 | 9.2% |
| Analysts Target Price | 63.7 | 9.2% |
ROL Fundamental Data Overview March 06, 2026
P/E Trailing = 53.211
P/E Forward = 48.5437
P/S = 7.419
P/B = 21.063
P/EG = 4.3645
Revenue TTM = 3.76b USD
EBIT TTM = 728.6m USD
EBITDA TTM = 853.3m USD
Long Term Debt = 486.1m USD (from longTermDebt, last quarter)
Short Term Debt = 261.1m USD (from shortTermDebt, last quarter)
Debt = 1.33b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.23b USD (from netDebt column, last quarter)
Enterprise Value = 29.13b USD (27.90b + Debt 1.33b - CCE 100.0m)
Interest Coverage Ratio = 25.51 (Ebit TTM 728.6m / Interest Expense TTM 28.6m)
EV/FCF = 44.82x (Enterprise Value 29.13b / FCF TTM 650.0m)
FCF Yield = 2.23% (FCF TTM 650.0m / Enterprise Value 29.13b)
FCF Margin = 17.28% (FCF TTM 650.0m / Revenue TTM 3.76b)
Net Margin = 14.00% (Net Income TTM 526.7m / Revenue TTM 3.76b)
Gross Margin = 51.91% ((Revenue TTM 3.76b - Cost of Revenue TTM 1.81b) / Revenue TTM)
Gross Margin QoQ = 47.52% (prev 54.44%)
Tobins Q-Ratio = 9.28 (Enterprise Value 29.13b / Total Assets 3.14b)
Interest Expense / Debt = 0.56% (Interest Expense 7.44m / Debt 1.33b)
Taxrate = 24.73% (38.3m / 154.7m)
NOPAT = 548.4m (EBIT 728.6m * (1 - 24.73%))
Current Ratio = 0.60 (Total Current Assets 472.7m / Total Current Liabilities 785.5m)
Debt / Equity = 0.97 (Debt 1.33b / totalStockholderEquity, last quarter 1.37b)
Debt / EBITDA = 1.44 (Net Debt 1.23b / EBITDA 853.3m)
Debt / FCF = 1.89 (Net Debt 1.23b / FCF TTM 650.0m)
Total Stockholder Equity = 1.43b (last 4 quarters mean from totalStockholderEquity)
RoA = 17.67% (Net Income 526.7m / Total Assets 3.14b)
RoE = 36.92% (Net Income TTM 526.7m / Total Stockholder Equity 1.43b)
RoCE = 38.09% (EBIT 728.6m / Capital Employed (Equity 1.43b + L.T.Debt 486.1m))
RoIC = 28.01% (NOPAT 548.4m / Invested Capital 1.96b)
WACC = 6.31% (E(27.90b)/V(29.23b) * Re(6.59%) + D(1.33b)/V(29.23b) * Rd(0.56%) * (1-Tc(0.25)))
Discount Rate = 6.59% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.14%
[DCF] Terminal Value 85.93% ; FCFF base≈622.0m ; Y1≈705.3m ; Y5≈960.1m
[DCF] Fair Price = 49.06 (EV 24.83b - Net Debt 1.23b = Equity 23.60b / Shares 481.1m; r=6.31% [WACC]; 5y FCF grow 15.61% → 2.90% )
EPS Correlation: 72.88 | EPS CAGR: 14.59% | SUE: -1.76 | # QB: 0
Revenue Correlation: 85.93 | Revenue CAGR: 12.31% | SUE: -2.84 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.34 | Chg7d=+0.000 | Chg30d=+0.001 | Revisions Net=+0 | Analysts=12
EPS current Year (2026-12-31): EPS=1.25 | Chg7d=+0.000 | Chg30d=-0.025 | Revisions Net=-13 | Growth EPS=+12.0% | Growth Revenue=+9.2%
EPS next Year (2027-12-31): EPS=1.41 | Chg7d=+0.000 | Chg30d=-0.014 | Revisions Net=-8 | Growth EPS=+12.2% | Growth Revenue=+8.8%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.1% (Discount Rate 7.9% - Earnings Yield 1.9%)
[Growth] Growth Spread = +2.7% (Analyst 8.8% - Implied 6.1%)
P/E Forward = 48.5437
P/S = 7.419
P/B = 21.063
P/EG = 4.3645
Revenue TTM = 3.76b USD
EBIT TTM = 728.6m USD
EBITDA TTM = 853.3m USD
Long Term Debt = 486.1m USD (from longTermDebt, last quarter)
Short Term Debt = 261.1m USD (from shortTermDebt, last quarter)
Debt = 1.33b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.23b USD (from netDebt column, last quarter)
Enterprise Value = 29.13b USD (27.90b + Debt 1.33b - CCE 100.0m)
Interest Coverage Ratio = 25.51 (Ebit TTM 728.6m / Interest Expense TTM 28.6m)
EV/FCF = 44.82x (Enterprise Value 29.13b / FCF TTM 650.0m)
FCF Yield = 2.23% (FCF TTM 650.0m / Enterprise Value 29.13b)
FCF Margin = 17.28% (FCF TTM 650.0m / Revenue TTM 3.76b)
Net Margin = 14.00% (Net Income TTM 526.7m / Revenue TTM 3.76b)
Gross Margin = 51.91% ((Revenue TTM 3.76b - Cost of Revenue TTM 1.81b) / Revenue TTM)
Gross Margin QoQ = 47.52% (prev 54.44%)
Tobins Q-Ratio = 9.28 (Enterprise Value 29.13b / Total Assets 3.14b)
Interest Expense / Debt = 0.56% (Interest Expense 7.44m / Debt 1.33b)
Taxrate = 24.73% (38.3m / 154.7m)
NOPAT = 548.4m (EBIT 728.6m * (1 - 24.73%))
Current Ratio = 0.60 (Total Current Assets 472.7m / Total Current Liabilities 785.5m)
Debt / Equity = 0.97 (Debt 1.33b / totalStockholderEquity, last quarter 1.37b)
Debt / EBITDA = 1.44 (Net Debt 1.23b / EBITDA 853.3m)
Debt / FCF = 1.89 (Net Debt 1.23b / FCF TTM 650.0m)
Total Stockholder Equity = 1.43b (last 4 quarters mean from totalStockholderEquity)
RoA = 17.67% (Net Income 526.7m / Total Assets 3.14b)
RoE = 36.92% (Net Income TTM 526.7m / Total Stockholder Equity 1.43b)
RoCE = 38.09% (EBIT 728.6m / Capital Employed (Equity 1.43b + L.T.Debt 486.1m))
RoIC = 28.01% (NOPAT 548.4m / Invested Capital 1.96b)
WACC = 6.31% (E(27.90b)/V(29.23b) * Re(6.59%) + D(1.33b)/V(29.23b) * Rd(0.56%) * (1-Tc(0.25)))
Discount Rate = 6.59% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.14%
[DCF] Terminal Value 85.93% ; FCFF base≈622.0m ; Y1≈705.3m ; Y5≈960.1m
[DCF] Fair Price = 49.06 (EV 24.83b - Net Debt 1.23b = Equity 23.60b / Shares 481.1m; r=6.31% [WACC]; 5y FCF grow 15.61% → 2.90% )
EPS Correlation: 72.88 | EPS CAGR: 14.59% | SUE: -1.76 | # QB: 0
Revenue Correlation: 85.93 | Revenue CAGR: 12.31% | SUE: -2.84 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.34 | Chg7d=+0.000 | Chg30d=+0.001 | Revisions Net=+0 | Analysts=12
EPS current Year (2026-12-31): EPS=1.25 | Chg7d=+0.000 | Chg30d=-0.025 | Revisions Net=-13 | Growth EPS=+12.0% | Growth Revenue=+9.2%
EPS next Year (2027-12-31): EPS=1.41 | Chg7d=+0.000 | Chg30d=-0.014 | Revisions Net=-8 | Growth EPS=+12.2% | Growth Revenue=+8.8%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.1% (Discount Rate 7.9% - Earnings Yield 1.9%)
[Growth] Growth Spread = +2.7% (Analyst 8.8% - Implied 6.1%)